Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lercanidipine + enalapril versus lercanidipine + hydrochlorothiazide in essential hypertension
2010-022232-37Phase 4Active
- Sponsor
- ASST Spedali Civili di Brescia
- Start
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of lercanidipine, enalapril and hydrochlorothiazide in essential hypertension (2 arms), sponsored by ASST Spedali Civili di Brescia. Primary endpoint: Endothelial progenitor cell number. Started Feb 2011; status: active.
02
Drugs
lercanidipineenalaprilhydrochlorothiazide
03
Conditions
essential hypertension
Beyond the preview
Go deeper on 2010-022232-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022232-37.